End-of-day quote
Saudi Arabian S.E.
06:00:00 2024-04-29 pm EDT
|
5-day change
|
1st Jan Change
|
27.2
SAR
|
+3.03%
|
|
-7.95%
|
+88.89%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
647.2
|
1,278
|
1,898
|
1,804
|
905.1
|
1,512
|
Enterprise Value (EV)
1 |
-410.3
|
1,093
|
1,576
|
1,335
|
580.9
|
1,252
|
P/E ratio
|
-4.25
x
|
409
x
|
51.4
x
|
-9.29
x
|
-2.87
x
|
7.5
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
0.34
x
|
0.59
x
|
1.12
x
|
1.06
x
|
0.4
x
|
0.44
x
|
EV / Revenue
|
-0.22
x
|
0.5
x
|
0.93
x
|
0.78
x
|
0.26
x
|
0.36
x
|
EV / EBITDA
|
2.09
x
|
21.7
x
|
25.4
x
|
-10.3
x
|
-1.83
x
|
6.16
x
|
EV / FCF
|
-1.65
x
|
-2.69
x
|
8.15
x
|
-6.19
x
|
4.27
x
|
7.68
x
|
FCF Yield
|
-60.6%
|
-37.1%
|
12.3%
|
-16.1%
|
23.4%
|
13%
|
Price to Book
|
1.94
x
|
1.81
x
|
2.5
x
|
1.78
x
|
1.4
x
|
1.65
x
|
Nbr of stocks (in thousands)
|
35,000
|
70,000
|
70,000
|
105,000
|
105,000
|
105,000
|
Reference price
2 |
18.49
|
18.26
|
27.11
|
17.18
|
8.620
|
14.40
|
Announcement Date
|
4/2/19
|
3/12/20
|
3/14/21
|
3/15/22
|
4/30/23
|
3/27/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,877
|
2,181
|
1,693
|
1,701
|
2,244
|
3,457
|
EBITDA
1 |
-196.6
|
50.44
|
62
|
-129.6
|
-317.5
|
203.2
|
EBIT
1 |
-204.5
|
43.42
|
54.9
|
-135.6
|
-323.9
|
195.7
|
Operating Margin
|
-10.9%
|
1.99%
|
3.24%
|
-7.97%
|
-14.44%
|
5.66%
|
Earnings before Tax (EBT)
1 |
-204.5
|
19.18
|
54.9
|
-135.6
|
-323.9
|
195.7
|
Net income
1 |
-204.5
|
3.124
|
36.91
|
-140.6
|
-315.2
|
201.5
|
Net margin
|
-10.9%
|
0.14%
|
2.18%
|
-8.26%
|
-14.05%
|
5.83%
|
EPS
2 |
-4.354
|
0.0446
|
0.5273
|
-1.850
|
-3.002
|
1.919
|
Free Cash Flow
1 |
248.5
|
-405.8
|
193.3
|
-215.6
|
136.2
|
163.1
|
FCF margin
|
13.24%
|
-18.6%
|
11.42%
|
-12.67%
|
6.07%
|
4.72%
|
FCF Conversion (EBITDA)
|
-
|
-
|
311.82%
|
-
|
-
|
80.27%
|
FCF Conversion (Net income)
|
-
|
-
|
523.73%
|
-
|
-
|
80.95%
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
4/2/19
|
3/12/20
|
3/14/21
|
3/15/22
|
4/30/23
|
3/27/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
1,057
|
185
|
322
|
468
|
324
|
260
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
249
|
-406
|
193
|
-216
|
136
|
163
|
ROE (net income / shareholders' equity)
|
-35.1%
|
0.45%
|
5.04%
|
-15.8%
|
-38%
|
24.8%
|
ROA (Net income/ Total Assets)
|
-3.59%
|
0.78%
|
0.93%
|
-2.13%
|
-4.96%
|
3.97%
|
Assets
1 |
5,696
|
402.2
|
3,953
|
6,614
|
6,350
|
5,079
|
Book Value Per Share
2 |
9.540
|
10.10
|
10.90
|
9.660
|
6.140
|
8.740
|
Cash Flow per Share
2 |
15.10
|
3.010
|
4.840
|
4.540
|
3.120
|
2.580
|
Capex
1 |
3.92
|
4.06
|
7.47
|
5.89
|
7.61
|
10
|
Capex / Sales
|
0.21%
|
0.19%
|
0.44%
|
0.35%
|
0.34%
|
0.29%
|
Announcement Date
|
4/2/19
|
3/12/20
|
3/14/21
|
3/15/22
|
4/30/23
|
3/27/24
|
|
1st Jan change
|
Capi.
|
---|
| +88.89% | 762M | | +13.03% | 9.62B | | -3.09% | 6.37B | | +14.44% | 5.96B | | +89.84% | 4.11B | | -2.30% | 2.35B | | +2.95% | 868M | | +5.81% | 159M | | -7.41% | 69.23M |
Health Insurance
|